CME Group Inc. $CME Shares Purchased by Aberdeen Group plc

Aberdeen Group plc grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 0.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 622,516 shares of the financial services provider’s stock after acquiring an additional 1,688 shares during the period. Aberdeen Group plc owned about 0.17% of CME Group worth $169,769,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of CME. Vanguard Group Inc. grew its stake in CME Group by 1.5% in the second quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider’s stock worth $9,695,313,000 after purchasing an additional 532,549 shares in the last quarter. Geode Capital Management LLC lifted its holdings in CME Group by 3.6% during the 2nd quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider’s stock worth $2,524,271,000 after buying an additional 319,899 shares during the last quarter. Norges Bank acquired a new position in shares of CME Group in the 2nd quarter worth approximately $1,571,447,000. Ameriprise Financial Inc. increased its holdings in shares of CME Group by 2.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider’s stock valued at $1,289,910,000 after acquiring an additional 92,925 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership increased its holdings in shares of CME Group by 6.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,833,090 shares of the financial services provider’s stock valued at $1,056,476,000 after acquiring an additional 238,522 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

CME has been the subject of a number of research reports. Piper Sandler lifted their price objective on shares of CME Group from $296.00 to $313.00 and gave the stock an “overweight” rating in a report on Thursday, November 13th. Weiss Ratings restated a “buy (b+)” rating on shares of CME Group in a research report on Monday, December 29th. Rothschild & Co Redburn lifted their price target on shares of CME Group from $300.00 to $333.00 and gave the company a “neutral” rating in a report on Thursday. UBS Group reiterated a “neutral” rating and set a $310.00 price objective on shares of CME Group in a research note on Friday, February 6th. Finally, Bank of America raised their target price on shares of CME Group from $201.00 to $209.00 in a report on Wednesday, December 10th. Nine analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat, CME Group presently has a consensus rating of “Hold” and an average price target of $299.53.

CME Group Price Performance

Shares of NASDAQ:CME opened at $303.07 on Friday. The firm’s 50 day moving average is $279.82 and its two-hundred day moving average is $274.00. The firm has a market capitalization of $109.29 billion, a P/E ratio of 27.16, a PEG ratio of 3.30 and a beta of 0.27. The company has a current ratio of 1.03, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52 week low of $244.43 and a 52 week high of $309.35.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, February 4th. The financial services provider reported $2.77 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.75 by $0.02. CME Group had a return on equity of 14.65% and a net margin of 62.45%.The business had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the company posted $2.52 EPS. The business’s revenue for the quarter was up 8.1% compared to the same quarter last year. Analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 26th. Stockholders of record on Tuesday, March 10th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. This is a positive change from CME Group’s previous quarterly dividend of $1.25. The ex-dividend date of this dividend is Tuesday, March 10th. CME Group’s dividend payout ratio is 44.80%.

Insider Activity at CME Group

In other CME Group news, CEO Terrence A. Duffy sold 25,000 shares of the firm’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $269.55, for a total transaction of $6,738,750.00. Following the transaction, the chief executive officer owned 65,804 shares of the company’s stock, valued at approximately $17,737,468.20. This trade represents a 27.53% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Dennis Suskind sold 748 shares of the business’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $300.00, for a total transaction of $224,400.00. Following the sale, the director owned 2,699 shares in the company, valued at $809,700. This trade represents a 21.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.

Key Headlines Impacting CME Group

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: CME raised shareholder payouts — the board declared a Q1 quarterly dividend of $1.30 (up from $1.25) and an annual variable dividend of $6.15 based on 2025 results (total ≈ $2.2B), both payable March 26; that boosts cash return to investors. CME Group Declares Annual Variable Dividend and Q1 2026 Quarterly Dividend
• Positive Sentiment: Analyst price-target lift — Rothschild & Co Redburn raised its CME price target to $333 from $300 (still a “neutral” rating), implying roughly 9.7% upside versus recent levels, which can support buying interest. Rothschild & Co Redburn Adjusts Price Target on CME Group to $333 From $300, Maintains Neutral Rating
• Positive Sentiment: New product rollout and execution — CME reported first trades in new Cardano, Chainlink and Stellar crypto futures and is actively exploring a rare-earths futures contract; these product additions expand fee pools and diversify revenue. CME Group Announces First Trades for New Cardano, Chainlink and Stellar Cryptocurrency Futures CME Weighs Launching First-Ever Rare Earth Futures Contract / Reuters
• Positive Sentiment: Asia expansion — reports say CME plans to list Taiwan and Hong Kong warehouses for aluminium futures in Asia, a move that could deepen regional market presence and increase volumes. Exclusive: CME to list Taiwan, Hong Kong warehouses in Asia aluminium push, sources say
• Neutral Sentiment: CFTC advisory involvement — the CFTC formed an Innovation Advisory Committee that includes a CME executive; this provides regulatory engagement but unclear near-term financial impact. CFTC Forms Innovation Advisory Committee With 35 Crypto and Finance Industry Leaders
• Neutral Sentiment: Board slate announced — CME named director nominees for the annual meeting; routine governance news that is unlikely to move the stock materially. CME Group Inc. Names Slate of Director Nominees
• Neutral Sentiment: Analyst/earnings commentary — recent analyst-question coverage from the Q4 call provides context for growth drivers but contains no new guidance. 5 Must-Read Analyst Questions From CME Group’s Q4 Earnings Call
• Negative Sentiment: Short-interest reporting is inconsistent — filings flagged a “significant increase” in February short interest but published data show zeros/NaN, creating ambiguity; if short interest is actually rising, that could add downward pressure.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.